Favorable benefit–risk ratio with teriflunomide treatment in relapsing-remitting multiple sclerosis: Results of the 2-year, multicenter, prospective, noninterventional TAURUS MS study in Austria
Titel:
Favorable benefit–risk ratio with teriflunomide treatment in relapsing-remitting multiple sclerosis: Results of the 2-year, multicenter, prospective, noninterventional TAURUS MS study in Austria
Auteur:
Guger, Michael Ackerl, Michael Matthias Heine, Martin Hofinger-Renner, Christiane Spiss, Heinrich Karl Taut, Andrea Unger, Karin Leutmezer, Fritz